What percent of ENTX is sold short?

37.3% of Entera Bio (ENTX) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is ENTX a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Entera Bio (ENTX).

ENTX Short Volume Hit 37.3%

$2.86

-0.03 (-1.04%)

Weekly Expected Move ±6.8%

$2 $3 $3 $3 $3

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 37 · $141.0M mcap · 40M float · 4.74% daily turnover · Short 38% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Short Volume Summary

2026-10-01

51.9%

Short Ratio

of total volume

51.2%

20-Day Avg

48.6%

50-Day Avg

▼ Falling

5-Day Trend

0.1M

Short Volume

0.2M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	99,912	170,055	58.8%
NYSE	19,767	60,595	32.6%

ENTX Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet